248 related articles for article (PubMed ID: 36274167)
21. Synthesis, Characterization, and Selective Delivery of DARPin-Gold Nanoparticle Conjugates to Cancer Cells.
Deyev S; Proshkina G; Ryabova A; Tavanti F; Menziani MC; Eidelshtein G; Avishai G; Kotlyar A
Bioconjug Chem; 2017 Oct; 28(10):2569-2574. PubMed ID: 28806065
[TBL] [Abstract][Full Text] [Related]
22. Highly specific hybrid protein DARPin-mCherry for fluorescent visualization of cells overexpressing tumor marker HER2/neu.
Mironova KE; Chernykh ON; Ryabova AV; Stremovskiy OA; Proshkina GM; Deyev SM
Biochemistry (Mosc); 2014 Dec; 79(12):1391-6. PubMed ID: 25716734
[TBL] [Abstract][Full Text] [Related]
23. Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions.
Jost C; Stüber JC; Honegger A; Wu Y; Batyuk A; Plückthun A
Protein Sci; 2017 Sep; 26(9):1796-1806. PubMed ID: 28639341
[TBL] [Abstract][Full Text] [Related]
24. Structural model for the interaction of a designed Ankyrin Repeat Protein with the human epidermal growth factor receptor 2.
Epa VC; Dolezal O; Doughty L; Xiao X; Jost C; Plückthun A; Adams TE
PLoS One; 2013; 8(3):e59163. PubMed ID: 23527120
[TBL] [Abstract][Full Text] [Related]
25. Assessing the use of tumor-specific DARPin-toxin fusion proteins for ex vivo purging of cancer metastases from human ovarian cortex before autotransplantation.
Eijkenboom L; Palacio-Castañeda V; Groenman F; Braat D; Beerendonk C; Brock R; Verdurmen W; Peek R
F S Sci; 2021 Nov; 2(4):330-344. PubMed ID: 35559858
[TBL] [Abstract][Full Text] [Related]
26. Efficient expression of fusion human epidermal growth factor in tobacco chloroplasts.
Wang Y; Fan J; Wei Z; Xing S
BMC Biotechnol; 2023 Jan; 23(1):1. PubMed ID: 36611158
[TBL] [Abstract][Full Text] [Related]
27. Expression and In Vitro Function of Anti-Breast Cancer Llama-Based Single Domain Antibody VHH Expressed in Tobacco Plants.
Park SR; Lee JH; Kim K; Kim TM; Lee SH; Choo YK; Kim KS; Ko K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079309
[TBL] [Abstract][Full Text] [Related]
28. Successful production of human epidermal growth factor in tobacco chloroplasts in a biologically active conformation.
Wang Y; Fan J; Ahmad N; Xin W; Wei Z; Xing S
Growth Factors; 2023 Feb; 41(1):20-31. PubMed ID: 36454601
[TBL] [Abstract][Full Text] [Related]
29. Bioengineering bacterial encapsulin nanocompartments as targeted drug delivery system.
Van de Steen A; Khalife R; Colant N; Mustafa Khan H; Deveikis M; Charalambous S; Robinson CM; Dabas R; Esteban Serna S; Catana DA; Pildish K; Kalinovskiy V; Gustafsson K; Frank S
Synth Syst Biotechnol; 2021 Sep; 6(3):231-241. PubMed ID: 34541345
[TBL] [Abstract][Full Text] [Related]
30. Selective staining and eradication of cancer cells by protein-carrying DARPin-functionalized liposomes.
Deyev S; Proshkina G; Baryshnikova O; Ryabova A; Avishai G; Katrivas L; Giannini C; Levi-Kalisman Y; Kotlyar A
Eur J Pharm Biopharm; 2018 Sep; 130():296-305. PubMed ID: 29959035
[TBL] [Abstract][Full Text] [Related]
31. Production of biopharmaceuticals and vaccines in plants via the chloroplast genome.
Daniell H
Biotechnol J; 2006 Oct; 1(10):1071-9. PubMed ID: 17004305
[TBL] [Abstract][Full Text] [Related]
32. Green biologics: The algal chloroplast as a platform for making biopharmaceuticals.
Taunt HN; Stoffels L; Purton S
Bioengineered; 2018 Jan; 9(1):48-54. PubMed ID: 28892417
[TBL] [Abstract][Full Text] [Related]
33. A 38-amino-acid sequence encompassing the arm domain of the cucumber necrosis virus coat protein functions as a chloroplast transit Peptide in infected plants.
Xiang Y; Kakani K; Reade R; Hui E; Rochon D
J Virol; 2006 Aug; 80(16):7952-64. PubMed ID: 16873252
[TBL] [Abstract][Full Text] [Related]
34. Bivalent EGFR-Targeting DARPin-MMAE Conjugates.
Karsten L; Janson N; Le Joncour V; Alam S; Müller B; Tanjore Ramanathan J; Laakkonen P; Sewald N; Müller KM
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269611
[TBL] [Abstract][Full Text] [Related]
35. Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process.
Houlihan G; Gatti-Lafranconi P; Lowe D; Hollfelder F
Protein Eng Des Sel; 2015 Sep; 28(9):269-79. PubMed ID: 26134501
[TBL] [Abstract][Full Text] [Related]
36. Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo.
Sokolova E; Proshkina G; Kutova O; Shilova O; Ryabova A; Schulga A; Stremovskiy O; Zdobnova T; Balalaeva I; Deyev S
J Control Release; 2016 Jul; 233():48-56. PubMed ID: 27178808
[TBL] [Abstract][Full Text] [Related]
37. Design and Construction of a Designed Ankyrin Repeat Protein (DARPin) Display Library.
Morselli M; Holton TR; Pellegrini M; Yeates TO; Arbing MA
Curr Protoc; 2024 Jan; 4(1):e960. PubMed ID: 38206591
[TBL] [Abstract][Full Text] [Related]
38. DARPins: an efficient targeting domain for lentiviral vectors.
Münch RC; Mühlebach MD; Schaser T; Kneissl S; Jost C; Plückthun A; Cichutek K; Buchholz CJ
Mol Ther; 2011 Apr; 19(4):686-93. PubMed ID: 21224833
[TBL] [Abstract][Full Text] [Related]
39. Barnase*Barstar-guided two-step targeting approach for drug delivery to tumor cells in vivo.
Shramova EI; Shilova MV; Ryabova AV; Dzhalilova DS; Zolotova NA; Telegin GB; Deyev SM; Proshkina GM
J Control Release; 2021 Dec; 340():200-208. PubMed ID: 34740723
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis-inducing anti-HER2 agents operate through oligomerization-induced receptor immobilization.
Stüber JC; Richter CP; Bellón JS; Schwill M; König I; Schuler B; Piehler J; Plückthun A
Commun Biol; 2021 Jun; 4(1):762. PubMed ID: 34155320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
